Open AccessRepeated Administration of Recombinant Human Insulin-Like Growth Factor-I in Patients After Gastric Surgery
Author(s) -
Christiane Goeters,
N. Mertes,
Jürgen Tacke,
U. Bolder,
Martin Kuhmann,
P. Lawin,
D Löhlein
Publication year - 1995
Publication title -
annals of surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.153
H-Index - 309
eISSN - 1528-1140
pISSN - 0003-4932
DOI - 10.1097/00000658-199511000-00007
Subject(s) - medicine , recombinant dna , insulin , surgery , administration (probate law) , insulin like growth factor , human insulin , growth factor , biochemistry , receptor , political science , law , gene , chemistry
The primary objective of this investigation was to evaluate the anticatabolic effects of repeated subcutaneous administration of recombinant human insulin-like growth factor-I (rhlGF-I) in patients after gastric surgery.